Randomized, open-label, phase three study comparing flutamide and abiraterone in patients with advanced prostate cancer after failure of first combined androgen blockade therapy.
Phase of Trial: Phase III
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; Flutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- 16 Apr 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 27 Feb 2015 New trial record